Company Filing History:
Years Active: 2018
Title: Hanna Eilken: Innovator in Medicinal Chemistry
Introduction
Hanna Eilken is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic agents. Her work focuses on innovative compounds that have the potential to treat various diseases.
Latest Patents
Hanna Eilken holds 1 patent for her invention titled "Substituted pyridobenzodiazepinone-derivatives and use thereof." This patent relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives. The application discusses processes for preparing these compounds and their use in treating or preventing diseases, especially those related to angiogenic disorders and hyperproliferative disorders, such as ophthalmological disorders and cancers. The treatments can be administered as monotherapy or in combination with other medications.
Career Highlights
Hanna Eilken is associated with Bayer Pharma Aktiengesellschaft, where she continues to advance her research in medicinal chemistry. Her innovative approach has positioned her as a key figure in the development of new therapeutic strategies.
Collaborations
Hanna collaborates with esteemed colleagues, including Andreas Schall and Jürgen Klar. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Hanna Eilken's contributions to medicinal chemistry exemplify the impact of innovative research on healthcare. Her patented work on pyridobenzodiazepinone derivatives showcases her commitment to developing effective treatments for complex diseases.